Johns Hopkins HIV Guide
Lopinavir/ritonavir
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals in adults and pediatric patients (14 days and older).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 10, 2023
Citation
Auwaerter, Paul G, and Paul A Pham. "Lopinavir/ritonavir." Johns Hopkins HIV Guide, 2023. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545123/all/Lopinavir_Ritonavir.
Auwaerter PG, Pham PA. Lopinavir/ritonavir. Johns Hopkins HIV Guide. 2023. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545123/all/Lopinavir_Ritonavir. Accessed November 29, 2023.
Auwaerter, P. G., & Pham, P. A. (2023). Lopinavir/ritonavir. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545123/all/Lopinavir_Ritonavir
Auwaerter PG, Pham PA. Lopinavir/ritonavir [Internet]. In: Johns Hopkins HIV Guide. ; 2023. [cited 2023 November 29]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545123/all/Lopinavir_Ritonavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lopinavir/ritonavir
ID - 545123
A1 - Auwaerter,Paul,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2023/09/10/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545123/all/Lopinavir_Ritonavir
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
